Notice of Results

RNS Number : 6069X

Cambridge Cognition Holdings PLC

23 February 2017

 

23 February 2017

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Notice of Results

The neuroscience digital health company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG) will be reporting its preliminary results for the twelve months ended 31 December 2016 on Wednesday 29 March 2017.

Enquiries

Cambridge Cognition Holdings PLC Steven Powell, Chief Executive Officer Noah Konig, Director of Marketing and Communications	Tel: [phone] [e-mail]
finnCap Ltd (NOMAD and Joint Broker) Geoff Nash / Simon Hicks Alice Lane	Tel: [phone] (Corporate Finance) (Corporate Broking)
Dowgate Capital Stockbrokers Limited David Poutney / James Serjeant	Tel: [phone]

Notes to editors

About Cambridge Cognition Holdings PLC

Cambridge Cognition is a neuroscience digital health company specialising in the precise measurement of clinical outcomes in neurological disorders. The Company develops and markets validated near patient assessment products using cognition as a biomarker to improve understanding, diagnosis and treatment in brain health worldwide.

Partners include the world's leading drug development companies, academic institutions and public-private health organisations.

www.cambridgecognition.com                  @CANTABconnect                       [e-mail] 

 

END

 

 

NORBIGDDSDDBGRD